To encourage responsible and
appropriate use of ICDs, CMS issued a Decision Memo for Implantable
Defibrillators on January 27, 2005, indicating that ICDs will be
covered for primary prevention of sudden cardiac death if the
beneficiary is enrolled in either an FDA-approved category B IDE
clinical trial (42 CFR #405.201), a trial under the CMS Clinical
Trial Policy (NCD Manual #310.1) or a qualifying prospective data
collection system (either a practical clinical trial or prospective
systematic data collection, which is sometimes referred to as a
registry).
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.